Copyright
©The Author(s) 2019.
World J Gastroenterol. Jul 21, 2019; 25(27): 3607-3618
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3607
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3607
Figure 2 Characteristics and management of patients treated with transarterial chemoembolization.
A: Kaplan Meier survival curves according to Barcelona Clinic Liver Cancer stage and treatment with/without trans-arterial chemoembolization; B: Survival according to radiological response after the first transarterial chemoembolization (TACE) evaluated by RECIST 1.1 criteria. BCLC: Barcelona clinic liver cancer.
- Citation: Piñero F, Marciano S, Fernández N, Silva J, Anders M, Zerega A, Ridruejo E, Romero G, Ameigeiras B, D’Amico C, Gaite L, Bermúdez C, Reggiardo V, Colombato L, Gadano A, Silva M. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis. World J Gastroenterol 2019; 25(27): 3607-3618
- URL: https://www.wjgnet.com/1007-9327/full/v25/i27/3607.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i27.3607